These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2424366)

  • 1. High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1986 Feb; 29(2):216-24. PubMed ID: 2424366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.
    Bongaerts GP; Kaptijn GM
    Antimicrob Agents Chemother; 1981 Sep; 20(3):344-50. PubMed ID: 6272630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):598-604. PubMed ID: 393165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):78-82. PubMed ID: 6289743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
    Saavedra S; Vera D; Ramírez-Ronda CH
    Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase.
    Lambert T; Gerbaud G; Courvalin P
    Antimicrob Agents Chemother; 1988 Jan; 32(1):15-9. PubMed ID: 2831812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aminoglycoside-modifying enzymes APH(3')-VIII and APH(3')-IX in Acinetobacter rudis and Acinetobacter gerneri.
    Yoon EJ; Grillot-Courvalin C; Courvalin P
    J Antibiot (Tokyo); 2017 Apr; 70(4):400-403. PubMed ID: 27965516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-inactivating enzymes of bacteria grown in subminimal inhibitory concentrations of antibiotics.
    Grassi GG
    Rev Infect Dis; 1979; 1(5):852-7. PubMed ID: 232298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-medicated aminoglycoside phosphotransferase of broad substrate range that phosphorylates amikacin.
    Courvalin P; Davies J
    Antimicrob Agents Chemother; 1977 Apr; 11(4):619-24. PubMed ID: 856013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of the disk diffusion test to detect tobramycin resistance in kanamycin-resistant Escherichia coli strains.
    Santanam P
    J Clin Microbiol; 1984 Aug; 20(2):295-7. PubMed ID: 6092419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi.
    Sanson-le Pors MJ; Casin IM; Collatz E
    Antimicrob Agents Chemother; 1985 Aug; 28(2):315-9. PubMed ID: 3010843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel aminoglycoside 2''-phosphotransferase identified in a gram-negative pathogen.
    Toth M; Frase H; Antunes NT; Vakulenko SB
    Antimicrob Agents Chemother; 2013 Jan; 57(1):452-7. PubMed ID: 23129050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, characterization, and cloning of a plasmid-borne gene encoding a phosphotransferase that confers high-level amikacin resistance in enteric bacilli.
    Gaynes R; Groisman E; Nelson E; Casadaban M; Lerner SA
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1379-84. PubMed ID: 2848443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification, characterization, and investigation of the mechanism of aminoglycoside 3'-phosphotransferase type Ia.
    Siregar JJ; Miroshnikov K; Mobashery S
    Biochemistry; 1995 Oct; 34(39):12681-8. PubMed ID: 7548020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isomeric DNA ladder formation of a plasmid encoding tobramycin resistance from Escherichia coli.
    Singh M; John JF
    J Antimicrob Chemother; 1991 Nov; 28(5):627-37. PubMed ID: 1685732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin.
    Calderwood SB; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1981 Apr; 19(4):549-55. PubMed ID: 6264851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin.
    Hull R; Klinger JD; Moody EE
    J Gen Microbiol; 1976 Jun; 94(2):389-94. PubMed ID: 781182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.